• Evergreen Theragnostics to Manufacture MTTI’s EvaThera Radiopharmaceuticals Platform ContractPharma
    December 02, 2021
    Molecular Targeting Technologies Inc. (MTTI) and Evergreen Theragnostics Inc., have entered an agreement in which Evergreen will manufacture MTTI's EvaThera platform of radiopharmaceuticals.
  • Evergreen Expands Alpha Radiopharmaceutical Production Capabilities Evergreen Theragnostics, a radiopharmaceutical contract development and manufacturing organization (CDMO), has undertaken an important strategic expansion at its manufacturing faci
    July 21, 2021
    A GMP state-of-the-art alpha emitter production center will be integrated into Evergreen’s existing facility.
  • Precirix, Evergreen Ink Clinical Supply Deal contractpharma
    April 30, 2021
    ​Precirix NV, a clinical-stage biotechnology company developing novel radiopharmaceuticals in oncology, and Evergreen Theragnostics, a radiopharmaceutical contract manufacturer, have entered into an agreement whereby Evergreen will provide U.S.-based ...
  • Precirix Partners with Evergreen Theragnostics contractpharma
    April 29, 2021
    Precirix NV and Evergreen Theragnostics Inc. have entered into an agreement whereby Evergreen will provide US-based manufacturing for Precirix's lead product candidate, CAM-H2.
PharmaSources Customer Service